According to Abivax's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -โน12.74 Billion a decrease over its 2022 earnings that were of -โน4.97 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 | -โน12.74 Billion | 156.52% |
2022 | -โน4.97 Billion | 31.02% |
2021 | -โน3.8 Billion | -5.92% |
2020 | -โน4.03 Billion | 25.5% |
2019 | -โน3.22 Billion | 68.74% |
2018 | -โน1.91 Billion | 30.93% |
2017 | -โน1.46 Billion | -10.5% |
2016 | -โน1.63 Billion | -5.29% |
2015 | -โน1.72 Billion | 224.09% |
2014 | -โน0.53 Billion | -39.76% |
2013 | -โน0.88 Billion |